Skip to main content
. 2020 Apr 18;77(6):748–754. doi: 10.1016/j.eururo.2020.03.039

Table 2.

Treatments and outcomes of 10 kidney transplant recipients infected with COVID-19.

Patient
n
1 2 3 4 5 6 7 8 9 10
Clinical condition
 Mild Yes Yes 2
 Severe Yes Yes Yes Yes Yes 5
 Critical Yes Yes Yes 3
IS adjustment
 M/Mi cessation No Yes Yes Yes Yes Yes Yes Yes Yes Yes 9
 Days of M/Mi cessation 12 30 21 20 24 12 14 11 18
 CNI cessation No No No Yes Yes Yes Yes Yes Yes Yes 7
 Days of CNI cessation 6 9 14 7 7 11 8
 CNI reduction No Yes No Yes Yes Yes Yes Yes Yes Yes 8
 Days of CNI reduction 12 15 5 8 7 5 11 10
Use of corticosteroid No No Yes Yes Yes Yes Yes Yes Yes Yes 8
 MP i.v. dose (mg/d) 20 40 20 40 40 40 40 20
 Days of MP i.v. 2 9 9 19 12 10 5 10
Use of IVIG No Yes No Yes Yes Yes Yes No Yes Yes 7
Antiviral therapy Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 10
Oxygen support
 Nasal cannula Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 10
 Noninvasive ventilation No Yes No No No Yes No No Yes No 3
Outcomes
 Discharge Yes Yes Yes Yes Yes No Yes Yes Death Yes 8
 Onset to shedding (d) 37 45 25 29 30 15 22 24
 Hospital stay (d) 16 43 30 16 26 45+ 13 25 6 21
 Onset to discharge (d) 43 48 37 37 34 49+ 20 34 31

CNI = calcineurin inhibitors; COVID-19 = coronavirus disease 2019; IS = immunosuppression; i.v. = intravenous; IVIG = intravenous immunoglobulin; M = mycophenolate mofetil; Mi = mizoribine; MP = methylprednisolone; n = total number of patients with available data.